CWM
IOVA icon

CIBC World Markets’s Iovance Biotherapeutics IOVA Stock Holding History

CIBC World Markets’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$55.5K Buy
+20,344
New +$47.1K ﹤0.01% 1193
2025
Q2 		$54.3K Sell
31,589
-29,346
-48% -$73K ﹤0.01% 1468
2025
Q1 		$203K Buy
60,935
+35,235
+137% +$182K ﹤0.01% 1472
2024
Q4 		$190K Buy
+25,700
New +$238K ﹤0.01% 1144

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIBC World Markets's IOVA Position: Q4 2025 in Review

CIBC World Markets opened a new position in Iovance Biotherapeutics (IOVA) in Q4 2025: 20,344 shares worth $55.5K. The stake represents ﹤0.01% of the portfolio and ranks #1193 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in IOVA as recently as Q2 2025.

CIBC World Markets first reported a position in IOVA in Q4 2024 and has held it in 4 quarters since. The position peaked at $203K in Q1 2025. 263 funds tracked by Wall St. Rank hold IOVA as of Q4 2025.

  • CIBC World Markets held 20,344 shares of Iovance Biotherapeutics worth $55.5K as of Q4 2025.
  • Iovance Biotherapeutics was a new CIBC World Markets position in Q4 2025.
  • Iovance Biotherapeutics made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #1193 holding.
  • CIBC World Markets first reported a position in Iovance Biotherapeutics in Q4 2024 and has held it in 4 quarters since.
  • CIBC World Markets's Iovance Biotherapeutics position peaked at $203K in Q1 2025.
  • 263 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.